Histological image of an ovarian cancer patient’s tumor analyzed for IL-4. Cancer cells expressing the gene PAX8 (green) also show IL-4 expression (red), which was found to help protect the cancer ...

Ovarian cancer starts in one or both ovaries, or in the fallopian tubes, or in the abdominal lining called the peritoneum. Women between the ages of 55 and 63 are most likely to get ovarian cancer.

Purple is common for pancreatic cancer but others in the United States are less common, like the teal ribbon for ovarian ...

This study has found that KNDy neurons are key to controlling ovarian function in mammals. These neurons express signalling molecules (peptides) in the brain that stimulate pulses of a hormone ...

Those shocking statistics explain why more and more people are embracing a reimagined breast-cancer-awareness ribbon that thinks ... Breast Cancer My Life in Pictures: Before, During, and After ...

signaling Ovarian Cancer Awareness Month. For women like Keli Fry, the ribbons are very personal. Looking at pictures of her ...

Ovarian cancer affects the ovaries – two small oval-shaped organs that are part of the female reproductive system. Cancer can occur in the ovaries when abnormal cells begin to grow and divide in ...

BEAUMONT, Texas — In honor of the upcoming National Breast Cancer Awareness Month, Gift of Life and the Young Men's Business League are installing nearly 200 eight ...

Considering taking supplements to treat ovarian cancer? Below is a list of common natural remedies used to treat or reduce the symptoms of ovarian cancer. Follow the links to read common uses ...

Your support makes all the difference. The world’s first vaccine for ovarian cancer has given hope to thousands. The joab is being developed in the UK and could wipe out the deadly disease ...

ovarian cancer progressing under taxane/carboplatin chemotherapy or in early relapse (< 6 months).

A university has secured funding from Cancer Research UK to develop a vaccine for ovarian cancer A laboratory hoping to develop a vaccine for ovarian cancer has been awarded funding. Scientists at ...